デフォルト表紙
市場調査レポート
商品コード
1789429

男性尿失禁市場:失禁タイプ別、製品タイプ別、使用タイプ別、エンドユーザー病院別、流通チャネル別、地域別

Male Urinary Incontinence Market, By Type of Incontinence, By Product Type Absorbent Products, By End User Hospitals, By Distribution Channel, By Geography


出版日
ページ情報
英文 135 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
男性尿失禁市場:失禁タイプ別、製品タイプ別、使用タイプ別、エンドユーザー病院別、流通チャネル別、地域別
出版日: 2025年07月31日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

男性尿失禁市場の2025年の市場規模は68億2,000万米ドルと推定され、2032年には101億9,000万米ドルに達すると予測され、2025~2032年までの年間平均成長率(CAGR)は5.9%で成長する見込みです。

レポート範囲 レポート詳細
基準年 2024年 2025年の市場規模 68億2,000万米ドル
実績データ 2020~2024年 予測期間 2025~2032年
予測期間:2025~2032年 5.90% 2032年の金額予測 101億9,000万米ドル

世界の男性尿失禁市場は、より広範なヘルスケア産業における重要なセグメントであり、世界中の何百万人もの男性に影響を及ぼしているにもかかわらず、あまり報告されていないことが多い病態に対処しています。男性尿失禁は、不随意に膀胱をコントロールできなくなることを特徴とし、ストレス性尿失禁、切迫性尿失禁、溢流性尿失禁、混合性尿失禁などさまざまなタイプがあり、それぞれに特有の臨床課題と治療要件があります。この疾患は主に高齢男性が罹患し、有病率は加齢とともに著しく増加しますが、前立腺手術、神経障害、外傷などの要因により若年者にも影響を及ぼすことがあります。

この市場には、失禁の根本的な原因を管理または治療するために設計された吸収性製品、外部カテーテル、埋め込み型器具、薬剤介入、外科的処置など、包括的な治療ソリューションが含まれています。男性尿失禁は、生活の質、社会的機能、心理的幸福に重大な影響を及ぼすにもかかわらず、依然として汚名を着せられており、罹患者の診断不足や治療を求める行動の遅れにつながっています。

市場力学

世界の男性尿失禁市場は主に、この治療領域における市場拡大と技術革新を総体的に推進するいくつかの相互関連要因によって牽引されています。世界人口の高齢化は最も重要な市場促進要因であり、尿失禁の有病率は年齢とともに、特に65歳以上の男性の間で大幅に増加し、管理ソリューションを必要とする患者数が増加しています。ヘルスケア組織や擁護団体による啓発キャンペーンや教育的イニシアチブの高まりにより、男性失禁にまつわる偏見が徐々に薄れ、より多くの男性が専門医の助けを求め、適切な治療法を選択するようになっています。先進的人工尿道括約筋、男性用スリング、低侵襲手術技術の開発を含む医療機器の技術的進歩は、治療の可能性を広げ、患者の転帰を改善しています。

さらに、外科的介入を必要とする前立腺肥大症や前立腺がんなどの前立腺関連疾患の有病率の増加は、男性尿失禁の発生率に直接的に寄与しており、それによって予防的と治療的ソリューションの両方に対する需要が高まっています。しかし、市場の成長は、この疾患に関連する根強い社会的烙印や恥ずかしさなどの重大な抑制要因に直面しており、これが過少報告や診断の遅れにつながり、市場浸透を制限しています。特に先進的外科手術や植え込み型医療機器にかかる高額な治療費は、特にヘルスケアインフラや保険適用が限定的な発展途上地域においては、アクセスを阻む大きな障壁となっています。医療機器の承認や薬事介入をめぐる規制の複雑さは、製品の上市を遅らせ、メーカーの開発コストを増大させています。医療インフラの改善と医療支出の増加が市場拡大の新たな道を開く新興市場には大きなビジネス機会が存在し、再生医療や生体工学的ソリューションなど、新たな治療アプローチに関する現在進行中の研究は、治療パラダイムを変革し、未開拓の市場ポテンシャルを獲得することを約束するものです。

本調査の主要特徴

  • 本レポートでは、世界の男性尿失禁市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模(10億米ドル)と年間平均成長率(CAGR%)を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の男性尿失禁市場の主要企業をプロファイルしています。
  • 本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • 男性尿失禁の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者を対象としています。
  • 利害関係者は、世界の男性尿失禁市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • ポーター分析
  • 合併と買収のシナリオ
  • 産業動向

第4章 世界の男性尿失禁市場、失禁タイプ別、2020~2032年

  • イントロダクション
  • 腹圧性尿失禁
  • 切迫性尿失禁
  • 溢流性尿失禁
  • 機能性尿失禁
  • 混合性失禁(腹圧性+切迫性)

第5章 世界の男性尿失禁市場、製品タイプ別、2020~2032年

  • イントロダクション
  • 吸収性製品
  • パッドとガード
  • 外部カテーテル(尿道シース)
  • ラテックスシース
  • 内部カテーテル
  • 留置型(フォーリー)カテーテル
  • 間欠カテーテル
  • その他のデバイスとシステム
  • 男性用スリング

第6章 世界の男性尿失禁市場、年齢層別、2020~2032年

  • イントロダクション
  • 18~39歳
  • 40~59歳
  • 60~74歳
  • 75歳以上

第7章 世界の男性尿失禁市場、使用タイプ別、2020~2032年

  • イントロダクション
  • 再利用可能
  • 使い捨て

第8章 世界の男性尿失禁市場、エンドユーザー別、2020~2032年

  • イントロダクション
  • 病院
  • 泌尿器科クリニック
  • 在宅ヘルスケア環境
  • 長期ケアセンター/介護施設
  • 外来手術センター
  • その他

第9章 世界の男性尿失禁市場、流通チャネル別、2020~2032年

  • イントロダクション
  • オフライン
  • オンライン

第10章 世界の男性尿失禁市場、地域別、2020~2032年

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • メキシコ
    • その他のラテンアメリカ
  • 欧州
    • ドイツ
    • 英国
    • スペイン
    • フランス
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • ASEAN諸国
    • その他のアジア太平洋
  • 中東
    • GCC諸国
    • イスラエル
    • その他の中東
  • アフリカ
    • 南アフリカ
    • 北アフリカ
    • 中央アフリカ

第11章 競合情勢

  • Coloplast A/S
  • ConvaTec Group PLC
  • Hollister Incorporated
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Boston Scientific Corporation
  • Braun Melsungen AG
  • Teleflex Incorporated
  • Wellspect HealthCare
  • Procter and Gamble Co.
  • AbbVie Inc.
  • Pfizer Inc.
  • Laboratoires URGO
  • Ontex Healthcare
  • R. Bard(BD)

第12章 アナリストの推奨事項

  • 機会
  • 一貫型機会マップ

第13章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI8346

Male Urinary Incontinence Market is estimated to be valued at USD 6.82 Bn in 2025 and is expected to reach USD 10.19 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.90% 2032 Value Projection: USD 10.19 Bn

The global male urinary incontinence market represents a critical segment within the broader healthcare industry, addressing a prevalent yet often underreported condition affecting millions of men worldwide. Male urinary incontinence, characterized by the involuntary loss of bladder control, encompasses various types including stress incontinence, urge incontinence, overflow incontinence, and mixed incontinence, each presenting unique clinical challenges and treatment requirements. This condition predominantly affects older men, with prevalence rates increasing significantly with age, though it can also impact younger individuals due to factors such as prostate surgery, neurological disorders, or traumatic injuries.

The market encompasses a comprehensive range of therapeutic solutions including absorbent products, external catheters, implantable devices, pharmaceutical interventions, and surgical procedures designed to manage or treat the underlying causes of incontinence. Despite the significant impact on quality of life, social functioning, and psychological well-being, male urinary incontinence remains stigmatized, leading to underdiagnosis and delayed treatment seeking behavior among affected individuals, which consequently influences market dynamics and growth patterns across different geographical regions.

Market Dynamics

The global male urinary incontinence market is primarily driven by several interconnected factors that collectively propel market expansion and innovation within this therapeutic area. The aging global population serves as the most significant market driver, as the prevalence of urinary incontinence increases substantially with age, particularly among men over 65 years, creating a growing patient pool requiring management solutions. Rising awareness campaigns and educational initiatives by healthcare organizations and advocacy groups are gradually reducing the stigma associated with male incontinence, encouraging more men to seek professional medical help and appropriate treatment options. Technological advancements in medical devices, including the development of sophisticated artificial urinary sphincters, male slings, and minimally invasive surgical techniques, are expanding treatment possibilities and improving patient outcomes.

Additionally, the increasing prevalence of prostate-related disorders, including benign prostatic hyperplasia and prostate cancer requiring surgical intervention, directly contributes to the incidence of male urinary incontinence, thereby driving demand for both preventive and therapeutic solutions. However, market growth faces significant restraints including persistent social stigma and embarrassment associated with the condition, leading to underreporting and delayed diagnosis, which limits market penetration. High treatment costs, particularly for advanced surgical procedures and implantable devices, pose substantial barriers to access, especially in developing regions with limited healthcare infrastructure and insurance coverage. Regulatory complexities surrounding medical device approvals and pharmaceutical interventions can delay product launches and increase development costs for manufacturers. Nevertheless, substantial opportunities exist within emerging markets where improving healthcare infrastructure and increasing healthcare expenditure create new avenues for market expansion, while ongoing research into novel therapeutic approaches, including regenerative medicine and bioengineered solutions, promises to revolutionize treatment paradigms and capture untapped market potential.

Key Features of the Study

  • This report provides an in-depth analysis of the global male urinary incontinence market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global male urinary incontinence market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Coloplast A/S, ConvaTec Group PLC, Hollister Incorporated, Kimberly-Clark Corporation, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Wellspect HealthCare, Procter and Gamble Co., AbbVie Inc., Pfizer Inc., Laboratoires URGO, Ontex Healthcare, and C. R. Bard (BD).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global male urinary incontinence market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global male urinary incontinence market.

Market Segmentation

  • Type of Incontinence Insights (Revenue, USD Bn, 2020 - 2032)
    • Stress Urinary Incontinence
    • Urge Urinary Incontinence
    • Overflow Urinary Incontinence
    • Functional Urinary Incontinence
    • Mixed Incontinence (Stress + Urge)
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Absorbent Products
    • Pads and Guards
    • Adult Diapers
    • Protective Underwear
    • Bed Protectors and Mattress Covers
    • External Catheters (Urinary Sheaths)
    • Latex Sheaths
    • Silicone Sheaths
    • Hydrocolloid Sheaths
    • Internal Catheters
    • Indwelling (Foley) Catheters
    • Intermittent Catheters
    • Other Devices and Systems
    • Male Slings
    • Artificial Urinary Sphincters
    • Electrical Stimulation Devices/Penile Clamps
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • 18-39 Years
    • 40-59 Year
    • 60-74 Years
    • 75 Years and Above
  • Usage Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Reusable
    • Disposable
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Urology Clinics
    • Home Healthcare Settings
    • Long-Term Care Centers / Nursing Homes
    • Ambulatory Surgical Centers
    • Others
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Offline
    • Online
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Coloplast A/S
    • ConvaTec Group PLC
    • Hollister Incorporated
    • Kimberly-Clark Corporation
    • Medtronic PLC
    • Boston Scientific Corporation
    • Braun Melsungen AG
    • Teleflex Incorporated
    • Wellspect HealthCare
    • Procter and Gamble Co.
    • AbbVie Inc.
    • Pfizer Inc.
    • Laboratoires URGO
    • Ontex Healthcare
    • R. Bard (BD)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Male Urinary Incontinence Market, By Type of Incontinence
    • Global Male Urinary Incontinence Market, By Product Type
    • Global Male Urinary Incontinence Market, By Age Group
    • Global Male Urinary Incontinence Market, By Usage Type
    • Global Male Urinary Incontinence Market, By End User
    • Global Male Urinary Incontinence Market, By Distribution Channel

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Male Urinary Incontinence Market, By Type of Incontinence, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Stress Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urge Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Overflow Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Functional Urinary Incontinence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Mixed Incontinence (Stress + Urge)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Male Urinary Incontinence Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Absorbent Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pads and Guards
    • Adult Diapers
    • Protective Underwear
    • Bed Protectors and Mattress Covers
  • External Catheters (Urinary Sheaths)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Latex Sheaths
    • Silicone Sheaths
    • Hydrocolloid Sheaths
  • Internal Catheters
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Indwelling (Foley) Catheters
  • Intermittent Catheters
  • Other Devices and Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Male Slings
    • Artificial Urinary Sphincters
    • Electrical Stimulation Devices/Penile Clamps

6. Global Male Urinary Incontinence Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 18-39 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 40-59 Year
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 60-74 Years
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 75 Years and Above
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Male Urinary Incontinence Market, By Usage Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reusable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Disposable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Male Urinary Incontinence Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Urology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Healthcare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Long-Term Care Centers / Nursing Homes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Male Urinary Incontinence Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Offline
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Male Urinary Incontinence Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type of Incontinence, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Usage Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Sub-region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Coloplast A/S
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • ConvaTec Group PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hollister Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Kimberly-Clark Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teleflex Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Wellspect HealthCare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Procter and Gamble Co.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AbbVie Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Laboratoires URGO
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ontex Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • R. Bard (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us